News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sophiris Bio Inc. (SHS.TO) Reports Fourth Quarter and Year-End 2012 Financial Results and Key Operational Highlights


2/14/2013 7:22:20 AM

San Diego, California and Vancouver, British Columbia, February 13, 2013 – Sophiris Bio Inc. (Sophiris, TSX: SHS) (the “Company”), a biopharmaceutical company developing a treatment for benign prostatic hyperplasia (BPH or enlarged prostate), today announced financial results and recent key operational highlights for the fourth quarter and the year-ended December 31, 2012.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES